These results suggest that PCOS rats present a state of chronic proliferative inflammation, and the intervention of SI can inhibit the NF-κB inflammatory signaling pathway, thereby reducing the release of downstream inflammatory factors and improving the inflammatory state. Here, NFKB1 is linked to polycystic ovary syndrome.